Aileron Therapeutics, Inc. (ALRN)
NASDAQ: ALRN · IEX Real-Time Price · USD
3.000
+0.260 (9.49%)
Jul 22, 2024, 9:42 AM EDT - Market open
Aileron Therapeutics Employees
Aileron Therapeutics had 15 employees as of December 31, 2023. The number of employees increased by 9 or 150.00% compared to the previous year.
Employees
15
Change (1Y)
9
Growth (1Y)
150.00%
Revenue / Employee
n/a
Profits / Employee
-$1,204,400
Market Cap
64.84M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Rockwell Medical | 237 |
Enzo Biochem | 190 |
HOOKIPA Pharma | 179 |
Vor Biopharma | 168 |
Allakos | 131 |
Mural Oncology | 117 |
ProPhase Labs | 113 |
VolitionRx | 110 |
ALRN News
- 21 days ago - Aileron Therapeutics to be Included in the Russell Microcap® Index - PRNewsWire
- 2 months ago - Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights - GlobeNewsWire
- 2 months ago - Aileron Therapeutics to Present at Two Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million - GlobeNewsWire
- 2 months ago - Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million - GlobeNewsWire
- 2 months ago - Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) - GlobeNewsWire
- 3 months ago - Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Aileron Therapeutics Announces CEO Transition - GlobeNewsWire